FGF19 and obesity due to melanocortin 4 receptor deficiency: By binding to the intestinal FXR, bile acids can induce the expression of endocrine hormone fibroblast growth factor 19 (FGF19), which suppresses lipogenesis and increases fatty acid oxidation in the liver, thereby regulating body weight gain and reducing the risk of obesity [48].